{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-056618","form_type":"8-K","ticker":"SMNR","cik":"0001913577","company_name":"Semnur Pharmaceuticals, Inc.","filed_at":"2023-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.059912+00:00","generated_at":"2026-06-13T08:58:51.706375+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Denali Capital extends business combination deadline to Oct 11, 2023 with $825K convertible note to FutureTech Capital","bullets":["Deposited $825,000 into trust account to extend deadline by three months from July 11 to October 11, 2023.","Issued convertible promissory note for $825,000 to FutureTech Capital LLC; convertible into Class A shares at $10 per share upon business combination.","Interest at lowest short-term Applicable Federal Rate; note matures upon business combination or liquidation.","This is the second of two permissible three-month extensions under the company's governing documents.","If no business combination, note will be repaid only from funds outside trust account or forfeited."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-056618","json":"https://secwatch.observer/filing/0001213900-23-056618.json","markdown":"https://secwatch.observer/filing/0001213900-23-056618.md","text":"https://secwatch.observer/filing/0001213900-23-056618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1913577/000121390023056618/0001213900-23-056618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1913577/000121390023056618/ea181625-8k425_denalicap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:58:51.706375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"fbba3fd1bcaebca634f676e7bc637bf78cfdffba","claim":"Semnur Pharmaceuticals, Inc. incurred convertible notes of $825,000 with FutureTech Capital LLC at interest equivalent to the lowest short-term Applicable Federal Rate maturing upon the earlier of (i) the closing of Denali's initial business combination and (ii) the date of the liquidation of Denali.","evidence_excerpt":"On July 11, 2023, Denali Capital Acquisition Corp. (“Denali”) issued a convertible promissory note (the “Convertible Promissory Note”) in the total principal amount of $825,000 to FutureTech Capital LLC, a Delaware Limited Liability Company (“FutureTech’).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1913577/000121390023056618/0001213900-23-056618-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$825,000"},{"label":"Counterparty","value":"FutureTech Capital LLC"},{"label":"Rate","value":"interest equivalent to the lowest short-term Applicable Federal Rate"},{"label":"Maturity","value":"upon the earlier of (i) the closing of Denali's initial business combination and (ii) the date of the liquidation of Denali"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}